Fernanda G. Herrera

Lausanne Branch, 
Lausanne, VD, CH 
Lausanne Branch, 
Lausanne, VD, CH 

Overview

Fernanda Herrera practices practicing medicine in Lausanne, Switzerland.

Her clinical expertise encompasses Prostate Cancer, Ovarian Cancer, Cervical Cancer, Endometrial Cancer, and Prostatectomy.

She is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Lausanne Branch, Lausanne, VD, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer
A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
RACIN, A Phase I Study of the Combination of Nivolumab Associated With Low-dose Radiation, Aspirin/ Celecoxib, and Either Ipilimumab or Low-dose Cyclophosphamide, Followed by Nivolumab Maintenance, in Patients With Advanced, TIL-negative Solid Tumors
RACIN, A Phase I Study of the Combination of Nivolumab Associated With Low-dose Radiation, Aspirin/ Celecoxib, and Either Ipilimumab or Low-dose Cyclophosphamide, Followed by Nivolumab Maintenance, in Patients With Advanced, TIL-negative Solid Tumors
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Combination product
Study Phase: Phase 1
View 1 Less Clinical Trial

87 Total Publications

Molecular Profiling to Guide Fertility Sparing Therapy in Early-Stage Endometrial Cancer: A EORTC Gynaecological Cancer Group Study.
Molecular Profiling to Guide Fertility Sparing Therapy in Early-Stage Endometrial Cancer: A EORTC Gynaecological Cancer Group Study.
Journal: Cancers
Published: June 06, 2026

Frequently Asked Questions about Fernanda G. Herrera

Is Fernanda G. Herrera a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Fernanda G. Herrera is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fernanda G. Herrera participate in research or clinical trials?

Yes. Fernanda G. Herrera has published 87 articles and abstracts on conditions like Prostate Cancer. You can view a list of Fernanda G. Herrera's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Herrera's expertise for a condition
ConditionClose
        View All 18 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile